Cargando…
Development and Validation of a Comprehensive Multivariate Dosimetric Model for Predicting Late Genitourinary Toxicity Following Prostate Cancer Stereotactic Body Radiotherapy
Purpose: Dosimetric predictors of toxicity after Stereotactic Body Radiation Therapy (SBRT) are not well-established. We sought to develop a multivariate model that predicts Common Terminology Criteria for Adverse Events (CTCAE) late grade 2 or greater genitourinary (GU) toxicity by interrogating th...
Autores principales: | Valle, Luca F., Ruan, Dan, Dang, Audrey, Levin-Epstein, Rebecca G., Patel, Ankur P., Weidhaas, Joanne B., Nickols, Nicholas G., Lee, Percy P., Low, Daniel A., Qi, X. Sharon, King, Christopher R., Steinberg, Michael L., Kupelian, Patrick A., Cao, Minsong, Kishan, Amar U. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7251156/ https://www.ncbi.nlm.nih.gov/pubmed/32509582 http://dx.doi.org/10.3389/fonc.2020.00786 |
Ejemplares similares
-
Clinical Assessment of Prostate Displacement and Planning Target Volume Margins for Stereotactic Body Radiotherapy of Prostate Cancer
por: Levin-Epstein, Rebecca, et al.
Publicado: (2020) -
Gantry-Mounted Linear Accelerator–Based Stereotactic Body Radiation Therapy for Low- and Intermediate-Risk Prostate Cancer
por: Dang, Audrey T., et al.
Publicado: (2019) -
Image-guided radiotherapy for prostate cancer
por: Dang, Audrey, et al.
Publicado: (2018) -
Prostate-Centric Versus Bony-Centric Registration in the Definitive Treatment of Node-Positive Prostate Cancer with Simultaneous Integrated Boost: A Dosimetric Comparison
por: Wu, Trudy C., et al.
Publicado: (2022) -
Magnetic resonance imaging-guided stereotactic body radiotherapy for prostate cancer (mirage): a phase iii randomized trial
por: Ma, Ting Martin, et al.
Publicado: (2021)